In early 2014, Stryker Corporation settled the first four Rejuvenate and ABGII hip replacement lawsuits filed since the Stryker hip recall. On March 15, 2014, eight more Stryker Rejuvenate hip lawsuits were settled. Following the resolution of the first four Rejuvenate cases, ten more were ordered to mediation by Judge Martinotti. One of those cases was delayed, and eight of the nine...

A motion filed recently seeks to consolidate all federal product liability lawsuits concerning the recalled Stryker Rejuvenate and ABG II hip implants. Lawsuits involving large numbers of affected people are sometimes consolidated into an MDL in order to better manage the cases; one court handles all discovery and pretrial proceedings, conserving resources and encouraging consistent rulings between lawsuits with similar legal issues. While saving time and money on the part of an overburdened court system is one goal of an MDL, allowing individuals who have been harmed by a defective product or drug to have their lawsuit heard in a timely manner is equally important.

At least ten Stryker Rejuvenate and ABGII hip implant lawsuits are expected to be centralized in the State of New Jersey before one judge in order to coordinate the handling of the suits. Application for Multi-county Litigation has been made in hopes of consolidating all Rejuvenate and ABGII lawsuits.